These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6263540)

  • 1. [Use of SQ 14225 in the treatment of essential arterial hypertension].
    Degli Esposti E; Chiarini C; Fusaroli M; Masi A; Santoro A; Sturani A; Zuccalà A; Zucchelli P
    Clin Ter; 1981 Apr; 97(2):153-63. PubMed ID: 6263540
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of angiotensin I to II converting enzyme inhibitor S.Q. 14225 (captopril), in moderate essential hypertension.
    Ryan E; Muldowney FP
    Ir Med J; 1983 Apr; 76(4):175, 177-8. PubMed ID: 6345457
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of captopril (SQ 14225) with hydrochlorothiazide in the treatment of essential hypertension.
    Aberg H; Frithz G; Mörlin C
    Int J Clin Pharmacol Ther Toxicol; 1981 Aug; 19(8):368-71. PubMed ID: 7030977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical experience with a new antihypertensive drug (captopril SQ 14.225), an oral inhibitor of converting enzyme].
    Santucci A; Aguglia F; Ficara C
    Clin Ter; 1981 Apr; 97(1):43-58. PubMed ID: 6269793
    [No Abstract]   [Full Text] [Related]  

  • 5. Arterial stiffness, hydrochlorothiazide and converting enzyme inhibition in essential hypertension.
    Bénétos A; Laflèche A; Asmar R; Gautier S; Safar A; Safar ME
    J Hum Hypertens; 1996 Feb; 10(2):77-82. PubMed ID: 8867559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of mild and moderate arterial hypertension with low doses of captopril].
    Alves Filho G; Santos TC; Carvalho OM; Guariento ME; Rizzalitti F; Rocha JC
    Arq Bras Cardiol; 1984 May; 42(5):377-80. PubMed ID: 6391438
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of captopril in essential hypertension (author's transl)].
    Mimran A; Targhetta R; Laroche B
    Nouv Presse Med; 1981 Apr; 10(19):1579-82. PubMed ID: 7025849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of essential arterial hypertension of moderate severity with an orally active inhibitor of the angiotensin converting enzyme (Captopril)].
    Guerrera G; Melina D
    Minerva Cardioangiol; 1983 Mar; 31(3):101-6. PubMed ID: 6304570
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
    Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
    Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy and safety of low doses of captopril, alone or combined with diuretics in the treatment of mild or moderate hypertension].
    Castilho F; Faria Neto A; Santos Neto FB; Assad JE; Levigard RM
    Arq Bras Cardiol; 1984 Oct; 43(4):283-6. PubMed ID: 6399202
    [No Abstract]   [Full Text] [Related]  

  • 11. [Efficacy and safety of captopril in low doses, alone or combined with diuretics, in the treatment of mild or moderate arterial hypertension].
    Dias GC
    Arq Bras Cardiol; 1984 Aug; 43(2):135-7. PubMed ID: 6398043
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of severe arterial hypertension with captopril (SQ 14.225) (author's transl)].
    Di Giulio S; Perez-Ramirez JL; Jamoun P; Grünfeld JP; Meyer P
    Nouv Presse Med; 1981 Apr; 10(19):1551-5. PubMed ID: 6269557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute inhibition of angiotensin-converting enzyme by captopril. Hemodynamic and biochemical aspects in normotension and essential hypertension].
    Stanek B; Templ H; Pohanka E; Silberbauer K
    Acta Med Austriaca; 1982; 9(5-6):175-80. PubMed ID: 6299046
    [No Abstract]   [Full Text] [Related]  

  • 14. [Captopril in mild or moderate systemic arterial hypertension].
    Spritzer N; Wolmeister H; Spritzer TS; Maciel R
    Arq Bras Cardiol; 1984 Jun; 42(6):447-50. PubMed ID: 6393923
    [No Abstract]   [Full Text] [Related]  

  • 15. Usefulness of orally active angiotensin I converting enzyme inhibitor (SQ 14,225) in the treatment of malignant hypertension.
    Abe I; Kawasaki T; Ueno M; Kawano Y; Uezono K; Ogata M; Kawazoe N; Omae T; Fukiyama K
    Fukuoka Igaku Zasshi; 1980 Mar; 71(3):157-66. PubMed ID: 6247259
    [No Abstract]   [Full Text] [Related]  

  • 16. Captopril, an orally active angiotensin I converting enzyme inhibitor in the treatment of renovascular and essential hypertension.
    Holtzman E; Rosenthal T; Stern N; Knecht A; Yaron A
    Isr J Med Sci; 1982 May; 18(5):597-602. PubMed ID: 6284678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antihypertensive effect of captopril in patients with mild or moderate systemic arterial hypertension].
    Savioli RM; Lima EV; Estrella LA; Puppi EJ; Praxedes JN; Nassif M; Stoeber GH; Del Nero Júnior E
    Arq Bras Cardiol; 1984 Jan; 42(1):67-71. PubMed ID: 6378150
    [No Abstract]   [Full Text] [Related]  

  • 18. Captopril - a genuine innovation.
    Drug Ther Bull; 1982 Feb; 20(4):13-5. PubMed ID: 6277587
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of angiotensin I converting enzyme inhibitor (SQ 14225) on arterial blood pressure].
    Watanabe H
    Nihon Jinzo Gakkai Shi; 1982 Apr; 24(4):405-19. PubMed ID: 6750185
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of refractory arterial hypertension with a converting enzyme inhibiting drug (Captopril)].
    Lavezzaro GC; Angelino PF; Gastaldo D; Minelli M; Paccotti P; Angeli A
    Minerva Cardioangiol; 1981 Oct; 29(10):519-25. PubMed ID: 7033830
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.